"Top-down" sale of pharmaceuticals
New challenges and barriers to conventional sale of pharmaceuticals. Key opinion leader communication. Key opinion leader identification. Stakeholder specific attitudes. History and rationale. New opportunities for Medical liasons and KAM's. How to ballance "services", "branding" and medical science.

Evidence Based Medicine and Quality Assessment of clinical science papers
History and rationale. Critical assessment of literature. Evidence ranking. Pro’s, con’s and limitations. National variations and cross border impact. Stakeholder specific attitudes

Introduction to Health Technology Assessment and the new medical decision paradigms
New public management and the story of HTA. International HTA-regulations and bodies. Practical use of HTA in medical decision making. International and Scandinavian links ot HTA institutions and reports.The concept of “mini-HTA”.

Introduction to Health Economy
Health Economic methods and concepts. Examples. Link to Health Economic assessments/modelling.

Organisation of the Danish Health Care System relevant to pharmaceutical companies
Governmental bodies and institutions and their role in reimbursement and market regulation. Regionalisation of decisions. Key opinion leader identification. Regulatory framework for hospital pharmaceuticals. Health political practice and financial key-figures.

Organisation of the Swedish Health Care System relevant to pharmaceutical companies
Governmental bodies and institutions and their role in reimbursement and market regulation. Regionalisation of decisions. Key opinion leader identification. Regulatory framework for hospital pharmaceuticals. Health political practice and financial key-figures.

Organisation of the Norwegian Health Care System relevant to pharmaceutical companies
Governmental bodies and institutions and their role in reimbursement and market regulation. Regionalisation of decisions. Key opinion leader identification. Regulatory framework for hospital pharmaceuticals. Health political practice and financial key-figures.

The patient as a decision maker
Organisational trends in patient involvement. Regulatory limitations. Growing influence from patients. New opportunities. Can Health care professionals represent the patients?

go back to services

Education /Lectures- educational programmes are adapted to your needs, please inquire